{"id":"https://openalex.org/W2123167369","doi":null,"title":"Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.","display_name":"Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.","publication_year":1999,"publication_date":"1999-08-15","ids":{"openalex":"https://openalex.org/W2123167369","mag":"2123167369","pmid":"https://pubmed.ncbi.nlm.nih.gov/10463606"},"language":"en","primary_location":{"id":"pmid:10463606","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10463606","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019221198","display_name":"Danila Valmori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117758","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02cn3rm21","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4210117758","https://openalex.org/I4210150094"]},{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"D Valmori","raw_affiliation_strings":["Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University of Lausanne, Switzerland. Danila.Valmori@inst.hospvd.ch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University of Lausanne, Switzerland. Danila.Valmori@inst.hospvd.ch","institution_ids":["https://openalex.org/I4210117758","https://openalex.org/I97565354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005627779","display_name":"Mika\u00ebl J. Pittet","orcid":"https://orcid.org/0000-0002-2060-4691","observed_orcids":["https://orcid.org/0000-0002-2060-4691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J Pittet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064729454","display_name":"C\u00e9dric Vonarbourg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Vonarbourg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071232781","display_name":"Donata Rimoldi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Rimoldi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113775106","display_name":"D. Li\u00e9nard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Li\u00e9nard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079146691","display_name":"Daniel E. Speiser","orcid":"https://orcid.org/0000-0003-2031-3250","observed_orcids":["https://orcid.org/0000-0003-2031-3250"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Speiser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022058325","display_name":"P. Rod Dunbar","orcid":"https://orcid.org/0000-0001-9626-2600","observed_orcids":["https://orcid.org/0000-0001-9626-2600"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Dunbar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000565081","display_name":"Vincenzo Cerundolo","orcid":"https://orcid.org/0000-0003-0040-3793","observed_orcids":["https://orcid.org/0000-0003-0040-3793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Cerundolo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111948358","display_name":"J C Cerottini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J C Cerottini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101424852","display_name":"Pedro J. Romero","orcid":"https://orcid.org/0000-0002-9688-2882","observed_orcids":["https://orcid.org/0000-0002-9688-2882","https://orcid.org/0000-0002-6995-5193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Romero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.3635,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.95421014,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"59","issue":"16","first_page":"4050","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.8339999914169312},{"id":"https://openalex.org/keywords/tyrosinase","display_name":"tyrosinase","score":0.875},{"id":"https://openalex.org/keywords/hla-a-0201","display_name":"HLA-A*0201","score":0.925000011920929},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8479999899864197},{"id":"https://openalex.org/keywords/tetramer-analysis","display_name":"tetramer analysis","score":0.6019999980926514},{"id":"https://openalex.org/keywords/post-translational-modification","display_name":"post-translational modification","score":0.871999979019165},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.7450000047683716},{"id":"https://openalex.org/keywords/antigen-specificity","display_name":"antigen specificity","score":0.5389999747276306},{"id":"https://openalex.org/keywords/melanoma-immunotherapy","display_name":"melanoma immunotherapy","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C87554066","wikidata":"https://www.wikidata.org/wiki/Q85942926","display_name":"Tyrosinase","level":3,"score":0.7408000230789185},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5574314594268799},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5486562252044678},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5415374040603638},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5152981281280518},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5131669640541077},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.49597081542015076},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.49257880449295044},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.43273186683654785},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37309008836746216},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32779040932655334},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.30679917335510254},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24986904859542847},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.10477283596992493},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06348991394042969}],"mesh":[{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014442","descriptor_name":"Monophenol Monooxygenase","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014442","descriptor_name":"Monophenol Monooxygenase","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015789","descriptor_name":"HLA-A2 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"pmid:10463606","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10463606","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unil.ch:iris/105263","doi":null,"is_oa":false,"landing_page_url":"https://iris.unil.ch/handle/iris/105263","pdf_url":null,"source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:serval.unil.ch:BIB_3B803475E5BD","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_3B803475E5BD","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer research, vol. 59, no. 16, pp. 4050-5","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2123167369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10463606","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1480063679","https://openalex.org/W1487106910","https://openalex.org/W1525721830","https://openalex.org/W1532659387","https://openalex.org/W1599999513","https://openalex.org/W1669593880","https://openalex.org/W1675195038","https://openalex.org/W1965517166","https://openalex.org/W1967219468","https://openalex.org/W2026082376","https://openalex.org/W2027075102","https://openalex.org/W2050253058","https://openalex.org/W2067069532","https://openalex.org/W2085022566","https://openalex.org/W2087231542","https://openalex.org/W2097666067","https://openalex.org/W2114657480","https://openalex.org/W2126261768","https://openalex.org/W2128984824","https://openalex.org/W2131363383","https://openalex.org/W2156677859","https://openalex.org/W2159703967","https://openalex.org/W2169840688"],"related_works":["https://openalex.org/W1965517166","https://openalex.org/W2087231542","https://openalex.org/W2114657480","https://openalex.org/W2108562020","https://openalex.org/W2054606142","https://openalex.org/W1480063679","https://openalex.org/W2064412243","https://openalex.org/W2014287557","https://openalex.org/W7097915781","https://openalex.org/W2068223792"],"abstract_inverted_index":{"The":[0],"human":[1],"tyrosinase":[2,19,62,110,133,160,190,211],"gene":[3],"codes":[4],"for":[5],"two":[6],"distinct":[7],"antigens":[8],"that":[9,159,223],"are":[10],"recognized":[11,218],"by":[12,25,114,219],"HLA-A*0201-restricted":[13],"CTLs.":[14],"For":[15],"one":[16],"of":[17,40,43,59,85,88,91,140,153,172,178,186,195,208],"them,":[18],"peptide":[20,63,111,134,161,191,212],"368-376,":[21],"the":[22,34,68,86,136,141,147,205,209,215,220],"sequence":[23,36],"identified":[24],"mass":[26],"spectrometry":[27],"in":[28,75,96,169,193,226],"melanoma":[29,81,103,128,173,198,228],"cell":[30,77],"eluates":[31],"differs":[32],"from":[33,79,101],"gene-encoded":[35],"as":[37],"a":[38,102],"result":[39],"posttranslational":[41],"modification":[42],"amino":[44],"acid":[45],"residue":[46],"370":[47],"(asparagine":[48],"to":[49,66,72,214],"aspartic":[50],"acid).":[51],"Here,":[52],"we":[53,105],"used":[54],"fluorescent":[55],"tetrameric":[56],"complexes":[57],"(\"tetramers\")":[58],"HLA-A*0201":[60],"and":[61,108,122,126],"368-376":[64,192,213],"(YMDGTMSQV)":[65],"characterize":[67],"CD8+":[69,93,163,187],"T-cell":[70],"response":[71],"this":[73],"antigen":[74,138],"lymphoid":[76],"populations":[78],"HLA-A2":[80,197,227],"patients.":[82,174,199,229],"Taking":[83],"advantage":[84],"presence":[87],"significant":[89,176,206],"numbers":[90,177],"tetramer-positive":[92],"T":[94,164],"cells":[95,100,165,180],"tumor-infiltrated":[97],"lymph":[98],"node":[99],"patient,":[104],"derived":[106],"polyclonal":[107],"monoclonal":[109],"368-376-specific":[112,162],"CTLs":[113,120,142,222],"tetramer-guided":[115],"flow":[116],"cytometric":[117,151],"sorting.":[118],"These":[119],"efficiently":[121],"specifically":[123],"lysed":[124],"HLA-A*0201-":[125],"tyrosinase-positive":[127],"cells.":[129],"As":[130],"assessed":[131],"with":[132,156,189],"variants,":[135],"fine":[137],"specificity":[139],"was":[143],"quite":[144],"diverse":[145],"at":[146],"clonal":[148],"level.":[149],"Flow":[150],"analysis":[152],"PBMCs":[154],"stained":[155],"tetramers":[157],"showed":[158],"were":[166,181],"hardly":[167],"detectable":[168],"peripheral":[170],"blood":[171],"However,":[175],"such":[179],"detected":[182],"after":[183],"short-term":[184],"stimulation":[185],"lymphocytes":[188],"6":[194],"10":[196],"Taken":[200],"together,":[201],"these":[202],"findings":[203],"emphasize":[204],"contribution":[207],"natural":[210],"antigenic":[216],"specificities":[217],"tumor-reactive":[221],"may":[224],"develop":[225]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}